These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16495076)

  • 1. The 5-HT2B antagonist and 5-HT4 agonist activities of tegaserod in the anaesthetized rat.
    McCullough JL; Armstrong SR; Hegde SS; Beattie DT
    Pharmacol Res; 2006 Apr; 53(4):353-8. PubMed ID: 16495076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo.
    Beattie DT; Smith JA; Marquess D; Vickery RG; Armstrong SR; Pulido-Rios T; McCullough JL; Sandlund C; Richardson C; Mai N; Humphrey PP
    Br J Pharmacol; 2004 Nov; 143(5):549-60. PubMed ID: 15466450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of 5-HT4 receptor-mediated esophageal responses by digital sonomicrometry in the anesthetized rat.
    Armstrong SR; McCullough JL; Beattie DT
    J Pharmacol Toxicol Methods; 2006; 53(3):198-205. PubMed ID: 16168678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT2B receptors do not modulate sensitivity to colonic distension in rats with acute colorectal hypersensitivity.
    Greenwood-Van Meerveld B; Campbell-Dittmeyer K; Johnson AC; Hicks GA
    Neurogastroenterol Motil; 2006 May; 18(5):343-5. PubMed ID: 16629860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity.
    Beattie DT; Armstrong SR; Shaw JP; Marquess D; Sandlund C; Smith JA; Taylor JA; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jul; 378(1):139-47. PubMed ID: 18408918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological profile of DA-6886, a novel 5-HT4 receptor agonist to accelerate colonic motor activity in mice.
    Lee MJ; Cho KH; Park HM; Sung HJ; Choi S; Im W
    Eur J Pharmacol; 2014 Jul; 735():115-22. PubMed ID: 24769304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cholinergic contractions of jejunal smooth muscle caused by a high cholesterol diet are prevented by the 5-HT4 agonist--tegaserod.
    Mathison R; Shaffer E
    BMC Gastroenterol; 2006 Feb; 6():8. PubMed ID: 16504074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated.
    Kennett GA; Trail B; Bright F
    Neuropharmacology; 1998 Dec; 37(12):1603-10. PubMed ID: 9886683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.
    Jarvie EM; North Laidler VJ; Corcoran S; Bassil A; Sanger GJ
    Br J Pharmacol; 2007 Feb; 150(4):455-62. PubMed ID: 17211452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rikkunshito, an herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT2 receptor antagonism.
    Takeda H; Sadakane C; Hattori T; Katsurada T; Ohkawara T; Nagai K; Asaka M
    Gastroenterology; 2008 Jun; 134(7):2004-13. PubMed ID: 18439428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contractile effect of the ghrelin receptor antagonist, D-Lys3-GHRP-6, in rat fundic strips is mediated through 5-HT receptors.
    Depoortere I; Thijs T; Peeters T
    Eur J Pharmacol; 2006 May; 537(1-3):160-5. PubMed ID: 16631731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in sensitivity of 5-HT receptor mediated functional responses in the rat oesophagus, fundus and jejunum following chronic infusion with 5-hydroxytryptamine.
    McLean PG; Coupar IM; Molenaar P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):513-9. PubMed ID: 8897456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DSP-6952, a novel 5-HT
    Mine Y; Itakura T; Oku S; Asada R; Shimizu I
    Eur J Pharmacol; 2018 May; 826():123-132. PubMed ID: 29428470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and in vitro effects of tegaserod, a serotonin 5-hydroxytryptamine 4 (5-HT4) receptor agonist with prokinetic activity in horses.
    Delco ML; Nieto JE; Craigmill AL; Stanley SD; Snyder JR
    Vet Ther; 2007; 8(1):77-87. PubMed ID: 17447227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inotropic effects of prokinetic agents with 5-HT(4) receptor agonist actions on human isolated myocardial trabeculae.
    Chai W; Chan KY; de Vries R; van den Bogeardt AJ; de Maeyer JH; Schuurkes JA; Villalón CM; Saxena PR; Danser AH; MaassenVanDenBrink A
    Life Sci; 2012 Apr; 90(13-14):538-44. PubMed ID: 22326501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SC-53606, a potent and selective antagonist of 5-hydroxytryptamine4 receptors in isolated rat esophageal tunica muscularis mucosae.
    Yang DC; Goldstin B; Moormann AE; Flynn DL; Gullikson GW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1339-47. PubMed ID: 8396633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional gastric contractility alterations in a diabetic gastroparesis mouse model: effects of cholinergic and serotoninergic stimulation.
    James AN; Ryan JP; Crowell MD; Parkman HP
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G612-9. PubMed ID: 15107299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety.
    Kennett GA; Bright F; Trail B; Baxter GS; Blackburn TP
    Br J Pharmacol; 1996 Apr; 117(7):1443-8. PubMed ID: 8730737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contractile serotonergic receptor in rat stomach fundus.
    Cohen ML; Fludzinski LA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):264-9. PubMed ID: 3668856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the 5-HT
    Nedi T; White PJ; Coupar IM; Irving HR
    BMC Res Notes; 2018 Jun; 11(1):362. PubMed ID: 29884229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.